We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock
PKBO

Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

9 hedge funds and large institutions have $2.53M invested in Peak Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

79% less funds holding

Funds holding: 43 → 9 (-34)

85% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 40

94% less capital invested

Capital invested by funds: $43.3M → $2.53M (-$40.8M)

Holders
9
Holders Change
-34
Holders Change %
-79.07%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
2
Closed
40
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
+$3.46M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$355K
3
Charles Schwab
Charles Schwab
California
+$268K
4
Northern Trust
Northern Trust
Illinois
+$99.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$21.3K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.24M
2
WRBC
W.R. Berkley Corp
Connecticut
-$3.7M
3
SCM
Saba Capital Management
New York
-$3.68M
4
CSS
Cubist Systematic Strategies
Connecticut
-$2.63M
5
DKCM
Davidson Kempner Capital Management
New York
-$2.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
26
Polar Asset Management Partners
Ontario, Canada
– -$748K -75,000 Closed
CM
27
Cohanzick Management
New York
– -$677K -67,827 Closed
ETH
28
Exos TFP Holdings
New York
– -$662K -66,343 Closed
WAM
29
Wolverine Asset Management
Illinois
– -$625K -62,660 Closed
Jane Street
30
Jane Street
New York
– -$572K -57,314 Closed
MTCM
31
Mint Tower Capital Management
Netherlands
– -$561K -56,218 Closed
CCM
32
Context Capital Management
California
– -$499K -50,000 Closed
MSU
33
Mizuho Securities USA
New York
– -$500K -50,000 Closed
YCM
34
Yakira Capital Management
Connecticut
– -$499K -50,000 Closed
DFCM
35
Dark Forest Capital Management
Puerto Rico
– -$492K -49,247 Closed
CH
36
CVI Holdings
Delaware
– -$472K -47,225 Closed
CM
37
Crestline Management
Texas
– -$457K -45,724 Closed
PMAM
38
Picton Mahoney Asset Management
Ontario, Canada
– -$400K -40,000 Closed
LCM
39
Landscape Capital Management
New Jersey
– -$377K -37,753 Closed
AA
40
AQR Arbitrage
Connecticut
– -$350K -35,000 Closed
CCM
41
CAAS Capital Management
New York
– -$251K -25,152 Closed
Walleye Capital
42
Walleye Capital
New York
– -$212K -21,205 Closed
RCM
43
Rivernorth Capital Management
Florida
– -$200K -20,000 Closed
HF
44
HRT Financial
New York
– -$199K -19,993 Closed
CF
45
Cantor Fitzgerald
New York
– -$160K -16,034 Closed
Walleye Trading
46
Walleye Trading
New York
– -$160K -16,000 Closed
SMC
47
Smith, Moore & Co
Missouri
– -$149K -14,880 Closed
Millennium Management
48
Millennium Management
New York
– -$125K -12,500 Closed
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$30K -3,000 Closed
1
2

PKBO Hedge Fund Activity: Q4 2022 in Review

9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q4 2022, worth a combined $2.53M — down 94% from $43.3M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of PKBO and 6 opened new positions — a net loss of 34 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Palo Alto Investors, opening a new position worth an estimated $3.46M. The largest seller was Deerfield Management, exiting entirely with an estimated $7.24M sold.

  • 9 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q4 2022, down from 43 in Q3 2022.
  • Funds reported $2.53M of Peak Bio, Inc. Common Stock stock for Q4 2022, down 94% quarter-over-quarter.
  • 6 funds opened new Peak Bio, Inc. Common Stock positions in Q4 2022 and 40 closed out, a net change of -34 holders.
  • The largest Peak Bio, Inc. Common Stock buyer in Q4 2022 was Palo Alto Investors, an estimated $3.46M added.
  • The largest Peak Bio, Inc. Common Stock seller in Q4 2022 was Deerfield Management, an estimated $7.24M sold.

Based on aggregated 13F filings for Q4 2022.